[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2633 followers Created: 2025-07-18 11:02:16 UTC $BMY Bristol Myers Squibb reports Phase X INDEPENDENCE Trial topline findings for Reblozyl® in adults with Myelofibrosis-Associated Anemia. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [$bmy](/topic/$bmy) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/OzmosiHealth/status/1946163606707667256)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2633 followers
Created: 2025-07-18 11:02:16 UTC
$BMY Bristol Myers Squibb reports Phase X INDEPENDENCE Trial topline findings for Reblozyl® in adults with Myelofibrosis-Associated Anemia.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
Related Topics $pph $xph $ibb $xbi more info $bmy stocks healthcare
/post/tweet::1946163606707667256